Physician profile
Clayton C Eiswirth
NPI 1639307861
$11,358.13
in general payments reported to CMS, 2019-2025
29 companies · $80.89 in 2025
The $80.89 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,581 · 2020: $3,340 · 2021: $1,578 · 2022: $1,509 · 2023: $1,218 · 2024: $50.14 · 2025: $80.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,348.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $5,684.27 | 2019-2023 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Glaxosmithkline, LLC. | $1,646.38 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $1,298.39 | 2019-2023 | Breztri, Fasenra, Tezspire |
| Sunovion Pharmaceuticals INC. | $419.00 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $286.91 | 2019-2023 | Dupixent |
| Genzyme Corporation | $279.27 | 2020-2024 | |
| Actelion Pharmaceuticals US, INC. | $246.99 | 2019-2023 | Uptravi, Opsumit |
| Janssen Pharmaceuticals, INC | $237.06 | 2019-2022 | |
| Mylan Specialty L.P. | $199.23 | 2019-2023 | Yupelri |
| United Therapeutics Corporation | $148.90 | 2019-2023 | Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $147.81 | 2021-2023 | |
| Grifols USA, LLC | $96.22 | 2020-2023 | Prolastin-C Liquid |
| Electromed, INC. | $82.06 | 2022-2023 | Smartvest |
| Genentech USA, INC. | $74.85 | 2019 | |
| Ethicon INC. | $72.97 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $65.40 | 2019-2023 | Arikayce |
| Philips North America LLC | $63.41 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $50.12 | 2019-2024 | Camzyos |
| Baxter Healthcare | $47.90 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Inogen, INC. | $39.28 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Inari Medical, INC. | $24.49 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Gilead Sciences, INC. | $24.25 | 2021 | |
| Merck Sharp & Dohme LLC | $21.60 | 2023 | |
| Amgen INC. | $20.18 | 2022 | |
| Paratek Pharmaceuticals, INC. | $19.40 | 2022 | |
| Olympus America INC. | $17.74 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.20 | 2020 | |
| Medtronic, INC. | $14.88 | 2021 | |
| Circassia INC. | $12.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clayton Eiswirth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.